Mental Health Clinics in Fogelsville, PA Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Brookhaven Center For Counseling And Development Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 2307 Cove Road, Fogelsville, PA 18051 Phone: 610-395-3005 Fax: 610-391-1711 |
Forensic Treatment Services Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 726 Church St, Fogelsville, PA 18051 Phone: 610-530-8392 Fax: 610-530-8940 |
David W Daley Do Pc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 7729 Main Street, Fogelsville, PA 18051 Phone: 610-366-0717 Fax: 610-366-0635 |
Mental-ease Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1742 Creek View Dr, Fogelsville, PA 18051 Phone: 484-951-7656 |
News Archive
Schizophrenics more likely to die from cardiovascular disease and cancer
A new study from Lund University in Sweden shows that the average life expectancy of men and women with schizophrenia is 15 years and 12 years shorter respectively than for those who do not suffer from the disease.
Diffusion-weighted MRI predicts liver fibrosis
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY.
Study compares two radiation therapy techniques available to women with breast cancer
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), according to researchers from The University of Texas MD Anderson Cancer Center.
Targeted nanoparticles offer promising techniques for cancer treatment
Researchers in the laboratory of Mark E. Davis at the California Institute of Technology have been using small interfering RNA (siRNA), sometimes known as silencing RNA, to "silence" specific genes that are implicated in certain malignancies.
Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme
Glioblastoma multiforme is among the most aggressive and difficult cancers to treat. Now, researchers at Penn State University have shown that a lipid-based nanoparticle, designed to bind to a specific receptor found on malignant brain cells but not healthy ones, improves the potency of a common anticancer drug and slows significantly the growth of glioblastoma in mice.
› Verified 8 days ago